Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The Company ...

TransMedics Group, Inc. ("TransMedics") , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the ...

Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will ...

Travere Therapeutics Inc. company and executive profile by Barron's. View the latest TVTX company infomation and executive bios.

LGND stock has risen more than 56.5% so far in 2026. Ligand doesn't make drugs; it forks over funding in exchange for Big ...

C dans l’air du 27 juillet 2026, invités et sommaire – Ce lundi et comme chaque soir sur France 5, […] Cet article C dans ...

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Travere Therapeutics, Inc. (NASDAQ: TVTX) breached their fiduciary duties to shareholders ...

Ett år før neste lokalvalg tegner det seg et bilde av et politisk landskap i Porsgrunn der de etablerte partiene kjemper om ...

L’opérateur d’État France Travail (ex-Pôle emploi) est sujet à bon nombre de dérives. Le mirage politicien du plein-emploi dans le système capitaliste conduit à des maltraitances envers les chômeurs ...

Dans un extrait de son spectacle partagé sur les réseaux sociaux, Bérangère Krief revient sur les accusations portées contre ...

Vera Therapeutics Inc. research and ratings by Barron's. View VERA revenue estimates and earnings estimates, as well as ...

Using a continuous glucose monitor improved time in range with no increase in hypoglycemia for people with type 2 diabetes ...